NCT01498289: A trial that was reported late by SWOG Cancer Research Network
This trial has reported, although it was 106 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT01498289 |
|---|---|
| Title | A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Feb. 29, 2012 |
| Completion date | March 31, 2018 |
| Required reporting date | March 31, 2019, midnight |
| Actual reporting date | July 15, 2019 |
| Date last checked at ClinicalTrials.gov | May 9, 2025 |
| Days late | 106 |